Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Intervention Indication Therapeutic Area Year Actions
Botulinum toxin type A for preventing episodic migraine Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Migraine Neurology 2023 View  |  Download
Brentuximab vedotin with doxorubicin, dacarbazine and vinblastine for previously untreated late-stage classical Hodgkin lymphoma Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Vinblastine (vinblastine sulfate) Hodgkin lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Budesonide suspension for treating eosinophilic oesophagitis in children and adolescents Budesonide orodispersible (Jorveza) Eosinophilic oesophagitis Gastroenterology , Immunology 2023 View  |  Download
Cabotegravir (long-acting injection) for prevention of HIV-1 infection Cabotegravir (GSK1265744) HIV-1 infection Infectious Disease 2023 View  |  Download
Cabozantinib with atezolizumab for treating metastatic castration-resistant prostate cancer after one novel hormonal therapy Atezolizumab (Tecentriq; MPDL3280A) , Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) Prostate cancer Haematological Cancer and Lymphomas , Oncology 2023 View  |  Download
Cabozantinib with nivolumab and ipilimumab for previously untreated advanced or metastatic renal cell carcinoma Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) , Ipilimumab (Yervoy; BMS 734016; MDX 101) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Renal cell carcinoma (RCC) Renal Cancer 2023 View  |  Download
Canagliflozin for type 2 diabetes mellitus in children and adolescents Canagliflozin (Invokana; canagliflozin hemihydrate) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Capivasertib with fulvestrant for HR+/HER2- locally advanced or metastatic breast cancer Capivasertib , Fulvestrant (Faslodex) Breast cancer Breast Cancer 2023 View  |  Download
Capivasertib with paclitaxel for previously untreated locally advanced or metastatic triple-negative breast cancer Capivasertib , Paclitaxel (Taxol; paclitaxel albumin) Breast cancer Breast Cancer 2023 View  |  Download
Ciclosporin ophthalmic solution for treating moderate-to-severe keratoconjunctivitis sicca (dry eye disease) Ciclosporin ophthalmic solution Keratoconjunctivitis sicca (dry eye disease) Ophthalmology 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications